Literature DB >> 24980433

MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24.

Takayoshi Yamauchi1, Masaaki Nishiyama1, Toshiro Moroishi1, Kanae Yumimoto1, Keiichi I Nakayama2.   

Abstract

MDM2 mediates the ubiquitylation and thereby triggers the proteasomal degradation of the tumor suppressor protein p53. However, genetic evidence suggests that MDM2 contributes to multiple regulatory networks independently of p53 degradation. We have now identified the DEAD-box RNA helicase DDX24 as a nucleolar protein that interacts with MDM2. DDX24 was found to bind to the central region of MDM2, resulting in the polyubiquitylation of DDX24 both in vitro and in vivo. Unexpectedly, however, the polyubiquitylation of DDX24 did not elicit its proteasomal degradation but rather promoted its association with preribosomal ribonucleoprotein (pre-rRNP) processing complexes that are required for the early steps of pre-rRNA processing. Consistently with these findings, depletion of DDX24 in cells impaired pre-rRNA processing and resulted both in abrogation of MDM2 function and in consequent p53 stabilization. Our results thus suggest an unexpected role of MDM2 in the nonproteolytic ubiquitylation of DDX24, which may contribute to the regulation of pre-rRNA processing.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24980433      PMCID: PMC4135551          DOI: 10.1128/MCB.00320-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

Review 1.  Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway.

Authors:  C Deisenroth; Y Zhang
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

Review 2.  Powering through ribosome assembly.

Authors:  Bethany S Strunk; Katrin Karbstein
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

3.  Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses.

Authors:  Heather L Ball; Bing Zhang; J Jacob Riches; Rikesh Gandhi; Jing Li; Johanna M Rommens; Jeremy S Myers
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

Review 4.  The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins.

Authors:  Sjoerd J L van Wijk; H T Marc Timmers
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

Review 5.  Mdm2-mediated ubiquitylation: p53 and beyond.

Authors:  J-C Marine; G Lozano
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

6.  S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains.

Authors:  Hyoung Tae Kim; Kwang Pyo Kim; Tomoaki Uchiki; Steven P Gygi; Alfred L Goldberg
Journal:  EMBO J       Date:  2009-04-23       Impact factor: 11.598

Review 7.  Signaling to p53: ribosomal proteins find their way.

Authors:  Yanping Zhang; Hua Lu
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

Review 8.  Building ubiquitin chains: E2 enzymes at work.

Authors:  Yihong Ye; Michael Rape
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

9.  Parvulin (Par14), a peptidyl-prolyl cis-trans isomerase, is a novel rRNA processing factor that evolved in the metazoan lineage.

Authors:  Sally Fujiyama-Nakamura; Harunori Yoshikawa; Keiichi Homma; Toshiya Hayano; Teruko Tsujimura-Takahashi; Keiichi Izumikawa; Hideaki Ishikawa; Naoki Miyazawa; Mitsuaki Yanagida; Yutaka Miura; Takashi Shinkawa; Yoshio Yamauchi; Toshiaki Isobe; Nobuhiro Takahashi
Journal:  Mol Cell Proteomics       Date:  2009-04-14       Impact factor: 5.911

10.  Nonconformity in ubiquitin compliance.

Authors:  Inbal Ziv; Oded Kleifeld; Michael Glickman
Journal:  EMBO J       Date:  2009-07-08       Impact factor: 11.598

View more
  8 in total

1.  FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells.

Authors:  Takayoshi Yamauchi; Masaaki Nishiyama; Toshiro Moroishi; Atsuki Kawamura; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2017-03-31       Impact factor: 4.272

2.  Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Authors:  Umama Z Siddiqi; Anup S Vaidya; Xinliu Li; Edyta Marcon; Sai Wah Tsao; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 3.  The TRiCky Business of Protein Folding in Health and Disease.

Authors:  Heba Ghozlan; Amanda Cox; Daniel Nierenberg; Stephen King; Annette R Khaled
Journal:  Front Cell Dev Biol       Date:  2022-05-05

4.  Negative regulation of the p300-p53 interplay by DDX24.

Authors:  D Shi; C Dai; J Qin; W Gu
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

5.  Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen.

Authors:  David Oliver; Hao Ji; Piaomu Liu; Alexander Gasparian; Ellen Gardiner; Samuel Lee; Adrian Zenteno; Lillian O Perinskaya; Mengqian Chen; Phillip Buckhaults; Eugenia Broude; Michael D Wyatt; Homayoun Valafar; Edsel Peña; Michael Shtutman
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

6.  DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera.

Authors:  Pengfei Pang; Xiaojun Hu; Bin Zhou; Junjie Mao; Yu Liang; Zaibo Jiang; Mingsheng Huang; Ruihong Liu; Youyong Zhang; Jiesheng Qian; Jinsong Liu; Jinxin Xu; Yaqin Zhang; Maoheng Zu; Yiming Wang; Huanhuan He; Hong Shan
Journal:  Hepatology       Date:  2019-01-06       Impact factor: 17.425

7.  Loss-of-function Mutations K11E or E271K Lead to Novel Tumor Suppression, Implicate Nucleolar Helicase DDX24 Oncogenicity.

Authors:  Xinglin Li; Xiaoyun Chen; Jiebing Gao; Jianzhong Xian; Zhijun Li; Lei Bi; Min Yang; Shuai Yang; Hongjun Jin; Hong Shan
Journal:  Int J Med Sci       Date:  2022-03-14       Impact factor: 3.738

8.  Identification and Characterization of USP7 Targets in Cancer Cells.

Authors:  Anna Georges; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.